An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...
Long Island Press on MSN
The breakthrough drug transforming HIV prevention: FDA-approved lenacapavir protects with twice-yearly injections
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that ...
Chemotherapy is often hindered by issues associated with deficient drug selectivity and ineluctable toxic effects.
For the first time since 2017, Canadian doctors have released updated clinical guidelines for antiretroviral medications used ...
In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...
The FDA approves two new drugs for gonorrhoea treatment, with Dr. Reddy’s to market one in Thailand and South Africa.
Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic ...
The healthcare leader wants to make waves in a potentially highly lucrative market.
GlobalData on MSN
“Sharp” funding cuts disrupt PrEP access to millions of HIV patients
PrEP has become an important tool in preventing HIV infection, helping reduce the risk of contracting the virus by up to 99%; however, its use has been disrupted this year. The AIDS Vaccine Advocacy ...
The Canadian Press on MSN
New HIV prevention guidelines say doctors should not be ‘gatekeeping’ PrEP access
New data released by the Public Health Agency of Canada on Monday said there were 1,826 new HIV diagnoses in 2024 ...
South Africa has begun administering lenacapavir, a long-acting HIV prevention drug, to selected individuals as part of a new study led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results